Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence

Idiopathic Hypersomnia Clinical Trial

Official title:

Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06251063
• Other study ID #: IRB-P00047080
• Status: Recruiting
• Phase: N/A
• Start date: April 1, 2024
• Est. completion date: May 1, 2025

Study information

• Verified date: April 2024
• Source: Boston Children's Hospital
• Contact: Grace Y Wang
• Phone: 617-919-6212
• Email: grace.wang[@]childrens.harvard.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to test a web-based psychoeducational resource for adolescents with central disorders of hypersomnolence and their families. The investigators hope to assess the website's usability, acceptability, and feasibility, as well as its potential effect on social relationship health. Participants will be asked to review the content of the psychoeducational websites. The participants will then provide feedback on the website, as well as the adolescent's social relationships and social health before and after reviewing the website through online surveys.

Description:

The American Academy of Sleep Medicine's clinical practice guideline task force concluded that "reliance on medications alone to treat CNS hypersomnia conditions is likely insufficient." Our stakeholder data demonstrated that this issue is a significant challenge in the domain of social relationship health for children with narcolepsy type 1 and 2 (NT1/NT2) and idiopathic hypersomnia (IH). With one peak for symptom onset in adolescence, a critical period in a child's social development, children with NT1/NT2/IH and their families report significant social sequelae of the disorder and its treatment that have lifelong implications. To address this important, yet consistently overlooked real-life concern for adolescents with CDH, the investigators intend to assess an online psychoeducational website that the investigators designed to provide families with the knowledge and resources to improve the adolescent's social relationship health. A total of 45 families will participate in a single-arm usability, feasibility, and acceptability trial. Eligible families will be provided with instructions on how to access the website. Participants will be encouraged to return to the website as often as needed to review content. For the purposes of this study, participants will be instructed to review all intervention materials within one month of receiving website access. The participants will then complete feedback questionnaires on the secure online platform REDCap. This study will inform a future randomized controlled trial testing the efficacy of the investigators' intervention. The investigators' stakeholder informed program will be the first of its kind for children with NT1/NT2/IH, with the potential to be widely disseminated.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 45
• Est. completion date: May 1, 2025
• Est. primary completion date: April 1, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 10 Years to 17 Years

Eligibility

Inclusion Criteria:

• Adolescent from 10-17 years of age and parent of the adolescent
• Adolescent has physician-diagnosed narcolepsy type 1 or type 2, or idiopathic hypersomnia
• English fluency
• Interest in learning more about how to improve social health for adolescents with a CDH

Related Conditions & MeSH terms

• Disorders of Excessive Somnolence
• Idiopathic Hypersomnia
• Narcolepsy
• Narcolepsy Type 1

Intervention

Behavioral:
• Web-based psychoeducational resource
The website will incorporate animations/illustrations to enhance comprehension, patient stories, and video-based expert explanations. The materials will address the following content areas: Provide families with data demonstrating how prevalent social relationship struggles are for children with CDH. Describe specific social challenges that commonly affect children with CDH. Explain the impact that medications typically prescribed for CDH may have on social relationship health. Help families advocate for their child's social needs at school. Support children and their families in decision-making about appropriate disclosure with peers at school and in extracurricular settings. Offer strategies to support families in raising the issue of social relationship health with the child's sleep physician. Provide a list of programming which offers children both structured and unstructured opportunities for social engagement

Locations

Country	Name	City	State
United States	Boston Children's Hospital	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Boston Children's Hospital	American Academy of Sleep Medicine

Country where clinical trial is conducted

United States, 

References & Publications (1)

Zhou ES, Revette A, Heckler GK, Worhach J, Maski K, Owens JA. Building a deeper understanding of social relationship health in adolescents with narcolepsy disorder. J Clin Sleep Med. 2023 Mar 1;19(3):491-498. doi: 10.5664/jcsm.10372. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Usability	System Usability Scale. The minimum score is 10 and the maximum score is 50. Each question is measured on a scale from 1-5. A higher score indicates higher usability (better outcome). Completed by both the parent and child.	5 weeks
Primary	Acceptability (Enrollment)	Proportion of eligible families who express interest in the study choosing to enroll.	5 weeks
Primary	Acceptability (Satisfaction)	Satisfaction subscale of the Usability, Satisfaction, and Ease of use scale. Each question is measured on a scale from 1-7. The minimum score is 7 and the maximum score is 49. A higher score indicates higher website satisfaction (better outcome).	5 weeks
Primary	Acceptability (Recommend Website)	Proportion of participants who respond positively to the Post-Intervention questionnaire item "Would you recommend this website to other families of children with NT1/NT2/IH?".	5 weeks
Primary	Feasibility (Website Access)	Proportion of participants that access the website at least once during the study period.	5 weeks
Primary	Feasibility (Assessment Completion)	Proportion of participants who complete the Post-Intervention Assessment.	5 weeks
Secondary	Relationship Quality	Patient Reported Outcomes Measurement Information System Pediatric Peer Relationships Scale (PROMIS-PPRS). Each question is measured on a scale of 0-4. The minimum score is 0 and the maximum score is 32. A higher score means better peer relationships (better outcome).	0 weeks and 5 weeks
Secondary	Social Problems (Loneliness)	UCLA Three-Item Loneliness Scale. Completed by patient and parent. Each question is measured on a scale of 1-3. The minimum score is 3 and the maximum score is 9. A higher score means more loneliness (worse outcome).	0 weeks and 5 weeks
Secondary	Social Problems (Social Relationships)	NIH Toolbox Pediatric Social Relationship Scales. Using the Emotional Support, Friendship, and Perceived Rejection Items. Each question is measured on a scale of 1-5. The minimum score is 19 and the maximum score is 95. A higher score means better social relationships (better outcome).	0 weeks and 5 weeks